Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
1. Evaluate the efficacy of adding anacetrapib 100 mg for 52 weeks relative to placebo on plasma concentrations of LDL-C. 2. Evaluate the safety and tolerability of 52 weeks of treatment with anacetrapib 100 mg.
Critère d'inclusion
- Heterozygous Familial Hypercholesterolemia